Sergio Quezada

35PUBLICATIONS
241CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Electrochemical energy storage and conversionHaematological tumoursMolecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 15, 2026
FasL-mediated death of activated intratumoral T cells drives secondary resistance to cancer immunotherapy.

|Apr 08, 2026
Synthetic super-enhancers enable precision viral immunotherapy.

Ute Koeber, Mantas Matjusaitis, Neza Alfazema

|Feb 05, 2026
Tumour-intrinsic features shape T cell differentiation through precursor to symptomatic multiple myeloma.

Kane A Foster, Elise Rees, Louise Ainley

|Jul 28, 2025
Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Gianmarco Leone, Yien Ning Sophia Wong, Robert J Jones

|Feb 19, 2025
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.

Maise Al Bakir, James L Reading, Samuel Gamble

|Nov 11, 2024
A modular protein language modelling approach to immunogenicity prediction.

Hugh O'Brien, Max Salm, Laura T Morton

Pageof 6

Frequent Collaborators

17 joint publications

Charles Swanton

8 joint publications

David A Moore

8 joint publications

Nicholas McGranahan

7 joint publications

James Reading